Metacrine, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Metacrine, Inc..The latest application filed is for "farnesoid x receptor agonists and uses thereof".
- Metacrine, Inc. - San Diego CA US
Trademarks
| Patent | Date |
|---|---|
| Farnesoid X Receptor Agonists And Uses Thereof App 20220089575 - SMITH; Nicholas D. ; et al. | 2022-03-24 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20220081390 - SMITH; Nicholas D. ; et al. | 2022-03-17 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20220056019 - SMITH; Nicholas D. ; et al. | 2022-02-24 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20220054469 - SMITH; Nicholas D. ; et al. | 2022-02-24 |
| Farnesoid X Receptor Agonists For The Treatment Of Disease App 20220047553 - SONG; Kenneth ; et al. | 2022-02-17 |
| Farnesoid X receptor agonists and uses thereof Grant 11,236,071 - Smith , et al. February 1, 2 | 2022-02-01 |
| Ssao Inhibitors And Uses Thereof App 20220002309 - SMITH; Nicholas D. ; et al. | 2022-01-06 |
| Farnesoid X receptor agonists and uses thereof Grant 11,214,538 - Smith , et al. January 4, 2 | 2022-01-04 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20210395253 - SMITH; Nicholas D. ; et al. | 2021-12-23 |
| Crystalline Forms Of A Farnesoid X Receptor Agonist App 20210347736 - SMITH; Nicholas D. ; et al. | 2021-11-11 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20210300875 - SMITH; Nicholas D. ; et al. | 2021-09-30 |
| Farnesoid X receptor agonists and uses thereof Grant 11,084,817 - Smith , et al. August 10, 2 | 2021-08-10 |
| Farnesoid X receptor agonists and uses thereof Grant 10,961,198 - Smith , et al. March 30, 2 | 2021-03-30 |
| Farnesoid X receptor agonists and uses thereof Grant 10,927,082 - Smith , et al. February 23, 2 | 2021-02-23 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20210032195 - SMITH; Nicholas D. ; et al. | 2021-02-04 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20200290973 - SMITH; Nicholas D. ; et al. | 2020-09-17 |
| Farnesoid X receptor agonists and uses thereof Grant 10,703,712 - Smith , et al. | 2020-07-07 |
| Ssao Inhibitors And Uses Thereof App 20200181104 - Smith; Nicholas D. ; et al. | 2020-06-11 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20200131132 - SMITH; Nicholas D. ; et al. | 2020-04-30 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20200131134 - SMITH; Nicholas D. ; et al. | 2020-04-30 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20200131142 - SMITH; Nicholas D. ; et al. | 2020-04-30 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20200131129 - SMITH; Nicholas D. ; et al. | 2020-04-30 |
| Farnesoid X receptor agonists and uses thereof Grant 10,626,081 - Smith , et al. | 2020-04-21 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20200102308 - SMITH; Nicholas D. ; et al. | 2020-04-02 |
| Farnesoid X receptor agonists and uses thereof Grant 10,377,717 - Smith , et al. A | 2019-08-13 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20190062277 - SMITH; Nicholas D. ; et al. | 2019-02-28 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20180282263 - SMITH; Nicholas D. ; et al. | 2018-10-04 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20180251429 - SMITH; Nicholas D. ; et al. | 2018-09-06 |
| Farnesoid X Receptor Agonists And Uses Thereof App 20180244606 - SMITH; Nicholas D. ; et al. | 2018-08-30 |
| Methods Of Treating Lipodystrophy Using Fgf-1 Compounds App 20180050087 - McDonnell; Neil ; et al. | 2018-02-22 |
| SEC | 0001634379 | Metacrine, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 